Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Brain Sciences|September 28, 2024
Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World EvidenceBianca Orlando, Gabriella Egeo, Cinzia Aurilia, et al.
Expert Opinion on Investigational Drugs|January 20, 2017
Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical developmentPiero Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2017
Ketogenic diet in migraine: rationale, findings and perspectivesPiero Barbanti, Luisa Fofi, Cinzia Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2017
The role of anti-CGRP antibodies in the pathophysiology of primary headachesPiero Barbanti, Cinzia Aurilia, Luisa Fofi, et al.
Sleep Medicine|January 16, 2013
A case-control study on excessive daytime sleepiness in chronic migrainePiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Headache|March 27, 2003
Sumatriptan in migraine with unilateral cranial autonomic symptoms: an open studyPiero Barbanti, Giovanni Fabbrini, Nicola Vanacore, et al.
Expert Opinion on Investigational Drugs|May 14, 2014
Drugs targeting nitric oxide synthase for migraine treatmentPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2017
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety studyLicia Grazzi, Gabriella Egeo, Eric Liebler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Excessive daytime sleepiness in de novo and treated Parkinson's diseaseGiovanni Fabbrini, Piero Barbanti, Cinzia Aurilia, et al.
Current Medical Research and Opinion|February 11, 2005
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migrainePiero Barbanti, Johannes A Carpay, W Jacqueline Kwong, et al.
Pageof 11